SEC EDGAR Filings

8-K - MARIZYME, INC. - 1.01 / 1.03 / 2.01 / 9.01

Filed: 2026-04-17 AccNo: 0001493152-26-017470 Size: 264 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.03: Bankruptcy or Receivership Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

查看原文来源主页查看事件簇按来源查看

发布时间04/17 15:14 UTC

首次发现04/17 15:20 UTC

热度107.2

重要度84

情绪+0.06

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。

sec_edgar_index_v1 · 858 字符

Form 8-K - Current report: SEC Accession No. 0001493152-26-017470

Filing Date: 2026-04-17

Accepted: 2026-04-17 11:14:41

Documents: 12

Period of Report: 2026-04-14

Items: Item 1.01: Entry into a Material Definitive Agreement Item 1.03: Bankruptcy or Receivership Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

MARIZYME, INC. (Filer) CIK : 0001413754 (see all company filings) EIN. : 825464863 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 26870284 SIC : 3841 Surgical & Medical Instruments & Apparatus (CF Office: 08 Industrial Applications and Services)

1 | 8-K | form8-k.htm iXBRL | 8-K

2 | EX-10.1 | ex10-1.htm | EX-10.1

3 | XBRL SCHEMA FILE | mrzm-20260414.xsd | EX-101.SCH

4 | XBRL LABEL FILE | mrzm-20260414_lab.xml | EX-101.LAB